In a study to determine safe dosages of the isotope astatine-211 for treating patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope’s potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
Monthly Archive for January, 2008
UnlockingBrainTumors.org, A Not For Profit Organization, Formed to Increase Brain Tumor Awareness and Fundraising
Posted in News on Jan 30th, 2008
UnlockingBrianTumors.org, a Not for Profit dedicated to raising and distributing funds for the continued research into brain tumors, today announced it has surpassed $50,000 in donor contributions since its inception.
People who receive high doses of the chemotherapy drug methotrexate to treat a certain type of brain tumor appear to live longer than people receiving other treatments, according to research published in the January 29, 2008, issue of Neurology®…
Oklahoma bill would boost coverage for clinical trial patients
Posted in Legislation, News on Jan 23rd, 2008
When doctors at Children’s Hospital in Oklahoma City told Steffanie Collings’ parents that her last, best hope to survive the tumor that invaded her brain would be a stem cell transplant, they readily agreed to the procedure.
Cancer Data? Sorry, Can’t Have It
Posted in News on Jan 22nd, 2008
Not long ago, I asked a respected cancer researcher if he could send me raw data from a trial he had recently published. He refused.
MGI PHARMA, INC. today announced that study results published in the February issue of the Journal of Neurosurgery show that treatment of patients who have recurrent glioblastoma multiforme (GBM) with both Gliadel(R) Wafer and radioactive seeds (iodine-125) at the time of tumor resection, may provide for a better outcome than treatment of patients with surgery and either agent alone.
Brain-tumor patients can get expert advice in Tampa this weekend
Posted in News on Jan 17th, 2008
Chuck Hale’s eyesight and hearing are fading. Words get tangled in his mouth, and he often struggles to concentrate. Blame the tumor in the left side of the Orlando man’s brain. Surgery, radiation and chemotherapy have stalled the growth of the cancer — an aggressive type of tumor called a glioblastoma.
Nanotubes Help Advance Brain Tumor Research
Posted in News on Jan 16th, 2008
Nanotechnology may help revolutionize medicine in the future with its promise to play a role in selective cancer therapy. City of Hope researchers hope to boost the brain’s own immune response against tumors by delivering cancer-fighting agents via nanotubes.
Groundbreaking, International Brain Tumor Study Recruits 125 Families, Enrolls Participants at all Study Sites
Posted in News on Jan 15th, 2008
The groundbreaking, international Gliogene (glioma gene) brain tumor study has already recruited 125 families and enrolled participants at all 15 study sites in the U.S., Europe and Israel.
An experimental brain tumor vaccine coaxes the immune system to attack diseased cells only. Trials on other cancers may follow.
-
-
Recent Posts
- Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Research
- Free Brain Tumor Conference Spotlights Treatment, Support
- Cottonseed-Based Drug Shows Promise Treating Severe Brain Cancer, Say UAB Researchers
- Jackson grad endures loss of home, brain tumor
- The Taking Tree: Late Effects Are Teh Awesome
Archives
Categories
-